SALMAN ABDUL WAHEED M.D. NPI 1104146505

NPI Information

  • NPI: 1104146505
  • Provider Name: SALMAN ABDUL WAHEED, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2614 W JEFFERSON ST
    JOLIET, IL
    ZIP 60435
  • Phone: (815) 725-1355

Map and Directions

Get Directions

NPI Details

Salman Abdul Waheed, M.D. is a hematology and oncology internal medicine in Joliet, IL with 16 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Salman Abdul Waheed, M.D. NPI is 1104146505. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Graduation Year:2010

The provider's business location address is:

2614 W JEFFERSON ST
JOLIET, IL
ZIP 60435-433
Phone: (815) 725-1355
Fax: (815) 725-9861

The NPI 1104146505 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Folic acid level, serum (HCPCS:82746)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Magnesium level (HCPCS:83735)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Phosphate level (HCPCS:84100)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Blood creatinine level (HCPCS:82565)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)

The enumeration date for this NPI number is 6/8/2010 and was last updated on 8/29/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology0125058084ILLINOISYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1036131969MEDICAIDILLINOIS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.